Skip to content

Clinical trials

Phase 1 Hepatic Insufficiency trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatic Insufficiency Phase: Phase 1 Country / region: United States Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20083
20093
20102
20111
20133
20142
20152
20173
20182
20193
20201
20221
20232
20244
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company10
Pfizer5
Merck Sharp & Dohme LLC4
Bristol-Myers Squibb3
Acerta Pharma BV2
Boehringer Ingelheim2
Allergan1
Bayer1
BeiGene1
Cassava Sciences, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatic Insufficiency42
Liver Diseases7
Lymphoma, Follicular2
Hepatitis C1
Neoplasm Metastasis1
Neoplasms1
Obesity1
Renal Insufficiency, Chronic1

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.